Globus Medical (GMED) Sees IPO Price of $16-$18/Share
Tweet Send to a Friend
In an amended S-1 filing Tuesday, Globus Medical (NYSE: GMED) disclosed it will offer 11,764,705 shares at a price ranging from $16-$18 per share. Globus plans to list on the New York Stock Exchange under the ticker, "GMED."
The offering is being made through BofA Merrill Lynch, Goldman, Sachs & Co., Piper Jaffray, Leerink Swann, Canaccord Genuity, William Blair & Company, and Oppenheimer & Co.
Globus Medical a medical device company focused exclusively on the design, development and commercialization of products that promote healing in patients with spine disorders.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The offering is being made through BofA Merrill Lynch, Goldman, Sachs & Co., Piper Jaffray, Leerink Swann, Canaccord Genuity, William Blair & Company, and Oppenheimer & Co.
Globus Medical a medical device company focused exclusively on the design, development and commercialization of products that promote healing in patients with spine disorders.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- WallachBeth Capital Starts Globus Medical (GMED) at Buy
- Ambit Biosciences (AMBI) IPO Opens Flat
- William Blair Cuts 3D Systems (DDD) to Underperform; Too Much Hype, Future is Cloudy
Create E-mail Alert Related Categories
IPOsRelated Entities
Piper Jaffray, William Blair, Merrill Lynch, Bank of America, S1, Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
